Oregon

The Division of Financial Regulation recently announced  permanent rulemaking repealing 836-053-0025, the regulation of the insulin co-pay amount for health benefit plans for the state, as a result of SB 1508 (2024) effective January 1, 2025.

Also in Oregon, the Division of Financial Regulation recently announced permanent rulemaking amending 836-052-1000, establishing and updating the list of prosthetic and orthotic devices; prohibiting internal or separate limits or caps on prosthetic and orthotic devices, other than the lifetime policy maximum, when permitted by law; and defining when coverage for prosthetic and orthotic device is provided through a managed care organization effective January 1, 2025.

Also in Oregon, the Prescription Drug Affordability Board (PDAB) posted an agenda and meeting materials for its December 18 meeting. You must register in advance to participate.

Finally in Oregon, the Oregon Prescription Drug Affordability Board has posted to the website the UPL report for the Oregon Legislature pursuant to ORS 646A.685.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.